Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

Share

Cytiva BioProcess R&D AB

Closing information (x1000 SEK)

Closing information 2022/12 2021/12 2020/12
Turnover 17,011,724 Less Arrow 14,786,287 Less Arrow 9,958,028
Financial expenses 11,543 More Arrow 13,201 Less Arrow 11,944
Earnings before taxes 9,901,946 Less Arrow 7,884,369 Less Arrow 3,212,993
EBITDA 16,485,575 Less Arrow 14,474,639 Less Arrow 9,802,006
Total assets 35,410,790 Less Arrow 26,555,022 More Arrow 41,468,776
Current assets 13,172,016 Less Arrow 246,748 More Arrow 8,583,433
Current liabilities 22,878,621 Less Arrow 13,444,433 Less Arrow 868,956
Equity capital 11,534,007 Less Arrow 10,665,472 More Arrow 37,497,072
- share capital 100 Equal arrow 100 Equal arrow 100
Employees (average) 0 Equal arrow 0 Equal arrow 0

Financial ratios

Fiscal year 2022/12 2021/12 2020/12
Solvency 32.6% More Arrow 40.2% More Arrow 90.4%
Turnover per employee
Profit as a percentage of turnover 58.2% Less Arrow 53.3% Less Arrow 32.3%
Return on assets (ROA) 28.0% More Arrow 29.7% Less Arrow 7.8%
Current ratio 57.6% Less Arrow 1.8% More Arrow 987.8%
Return on equity (ROE) 85.9% Less Arrow 73.9% Less Arrow 8.6%
Change turnover 2,225,437 More Arrow 4,828,259 Less Arrow 3,167,885
Change turnover % 15% More Arrow 48% Less Arrow 47%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees %

Total value of public sale

Fiscal year 2022/12 2021/12 2020/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.